Skip to content

Alere Analytics Demonstrates INR Home Monitoring Program at Aprima User Conference 2014

August 11, 2014

Alere Analytics demonstrated our Home INR Monitoring Program at the Aprima User Conference 2014, from August 8 – 10, in Dallas, TX.  Annually,  Aprima Electronic Health Record (EHR) clients and users gather to share knowledge, gain insights from Health IT industry leaders, and discuss innovations on how best to utilize EHRs to improve patient care and reduce costs of treatment.


photo 5

Our VP of Sales, Roger Panduro, welcomes Aprima UC attendees to the Alere booth


This year, we debuted our new Home INR Monitoring Patient Eligibility program, which will soon be available for Clinical Decision Support (CDS) integration for Aprima users. This CDS alert enables providers to know which of their Warfarin/Coumadin patients may be eligible for Alere’s Home INR Monitoring  – a home monitoring program that helps keep patients on anticoagulation therapies in normal range and alerts providers if a test result requires immediate attention – thus allowing more freedom for patients and helping to improve clinical and operational efficiencies for physicians.


photo 1

Our Chief of Clinical Affairs, Dr. FX Campion, and Roger, meet with an Aprima UC attendee at the Alere booth


Thanks to all who stopped by our booth and watched a demonstration of Alere’s Home INR Monitoring program!


If you’re interested in learning more about Home INR Monitoring, please visit Alere’s informational Website For the latest news on Alere Analytics, visit our News & Events section on


No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: